# Verisign Inc: overview

VRSN · Nasdaq · CIK 1014473 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrsn.md) · [Financials](/companies/vrsn/financials.md) · [Filings](/companies/vrsn/filings.md) · [Insiders](/companies/vrsn/insiders.md)

Latest reported revenue: [$443.0m](/filings/0001014473-26-000039.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:Revenues, accession 0001014473-26-000039).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [395 d](/filings/0001014473-26-000006.md) | [402](/filings/0001014473-26-000020.md) | [410](/filings/0001014473-26-000028.md) | [419](/filings/0001014473-26-000039.md) | [425 d](/filings/0001014473-26-000006.md) | [429](/filings/0001014473-26-000020.md) | [435](/filings/0001014473-26-000028.md) | [443](/filings/0001014473-26-000039.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [66.7% d](/filings/0001014473-26-000006.md) | [67.4%](/filings/0001014473-26-000020.md) | [68.5%](/filings/0001014473-26-000028.md) | [67.8%](/filings/0001014473-26-000039.md) | [67.0% d](/filings/0001014473-26-000006.md) | [68.5%](/filings/0001014473-26-000020.md) | [68.2%](/filings/0001014473-26-000028.md) | [66.9%](/filings/0001014473-26-000039.md) |
| Net margin | % | [48.4% d](/filings/0001014473-26-000006.md) | [49.5%](/filings/0001014473-26-000020.md) | [50.6%](/filings/0001014473-26-000028.md) | [50.8%](/filings/0001014473-26-000039.md) | [48.5% d](/filings/0001014473-26-000006.md) | [50.0%](/filings/0001014473-26-000020.md) | [49.8%](/filings/0001014473-26-000028.md) | [48.0%](/filings/0001014473-26-000039.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [222 d](/filings/0001014473-26-000006.md) | [286](/filings/0001014473-26-000020.md) | [195 d](/filings/0001014473-26-000028.md) | [303 d](/filings/0001014473-26-000039.md) | [285 d](/filings/0001014473-26-000006.md) | [265](/filings/0001014473-26-000020.md) | [213 d](/filings/0001014473-26-000028.md) | [261 d](/filings/0001014473-26-000039.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,328](/filings/0001014473-24-000006.md) | [1,425](/filings/0001014473-25-000006.md) | [1,493](/filings/0001014473-26-000006.md) | [1,557](/filings/0001014473-26-000006.md) | [1,657](/filings/0001014473-26-000006.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [65.3%](/filings/0001014473-24-000006.md) | [66.2%](/filings/0001014473-25-000006.md) | [67.0%](/filings/0001014473-26-000006.md) | [67.9%](/filings/0001014473-26-000006.md) | [67.7%](/filings/0001014473-26-000006.md) |
| Net margin | % | [59.1%](/filings/0001014473-24-000006.md) | [47.3%](/filings/0001014473-25-000006.md) | [54.8%](/filings/0001014473-26-000006.md) | [50.4%](/filings/0001014473-26-000006.md) | [49.8%](/filings/0001014473-26-000006.md) |
| Diluted EPS | $ per share | [7.00](/filings/0001014473-23-000005.md) | [6.24](/filings/0001014473-23-000005.md) | not reported | not reported | not reported |
| Free cash flow | $m | [754](/filings/0001014473-24-000006.md) | [804](/filings/0001014473-25-000006.md) | [808](/filings/0001014473-26-000006.md) | [875](/filings/0001014473-26-000006.md) | [1,068](/filings/0001014473-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vrsn/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Bidzos D James](/insiders/1204816.md) | Exec. Chairman, Pres, & CEO, Director, Officer | Sale (S) | 1,100 | $305.2564 | $335.8k | [Form 4](/filings/0001204816-26-000057.md) |
| 2026-10-27 | [Bidzos D James](/insiders/1204816.md) | Exec. Chairman, Pres, & CEO, Director, Officer | Sale (S) | 900 | $304.6322 | $274.2k | [Form 4](/filings/0001204816-26-000057.md) |
| 2026-10-27 | [Bidzos D James](/insiders/1204816.md) | Exec. Chairman, Pres, & CEO, Director, Officer | Sale (S) | 400 | $302.69 | $121.1k | [Form 4](/filings/0001204816-26-000057.md) |
| 2026-10-27 | [Bidzos D James](/insiders/1204816.md) | Exec. Chairman, Pres, & CEO, Director, Officer | Sale (S) | 600 | $301.6355 | $181.0k | [Form 4](/filings/0001204816-26-000057.md) |
| 2026-10-27 | [Bidzos D James](/insiders/1204816.md) | Exec. Chairman, Pres, & CEO, Director, Officer | Sale (S) | 300 | $300.3067 | $90.1k | [Form 4](/filings/0001204816-26-000057.md) |
| 2026-10-26 | [McPherson Danny R](/insiders/1940987.md) | EVP - Technology & CSO, Officer | Sale (S) | 3,256 | $303.895 | $989.5k | [Form 4](/filings/0001940987-26-000022.md) |
| 2025-07-30 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Sale (S) | 4,300,000 | $282.15 | $1.21bn | [Form 4](/filings/0000950170-25-101546.md) |
| 2025-01-03 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 800 | $204.9429 | $164.0k | [Form 4](/filings/0000950170-25-001530.md) |
| 2025-01-03 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 11,744 | $204.6057 | $2.4m | [Form 4](/filings/0000950170-25-001530.md) |
| 2025-01-02 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 5,879 | $204.8429 | $1.2m | [Form 4](/filings/0000950170-25-001530.md) |
| 2024-12-31 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 1,621 | $204.8282 | $332.0k | [Form 4](/filings/0000950170-25-001530.md) |
| 2024-12-30 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 9,741 | $204.8507 | $2.0m | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-30 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 11,730 | $204.402 | $2.4m | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-30 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 5,000 | $203.2741 | $1.0m | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-27 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 305 | $206.0378 | $62.8k | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-27 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 2,498 | $205.3999 | $513.1k | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-27 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 4,751 | $204.1902 | $970.1k | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-27 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 17,932 | $203.787 | $3.7m | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-27 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 6,619 | $202.5082 | $1.3m | [Form 4](/filings/0000950170-24-141263.md) |
| 2024-12-26 | [Berkshire Hathaway Inc](/insiders/1067983.md) | 10% owner | Purchase (P) | 106 | $203.13 | $21.5k | [Form 4](/filings/0000950170-24-141263.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Berkshire Hathaway Inc](/funds/1067983.md) | 2026-06-30 | $2.26bn | 8,989,880 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.12bn | 8,412,124 |  | Reduced −912,212 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.35bn | 5,348,923 |  | Reduced −14,982 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.28bn | 5,075,673 |  | Reduced −171,816 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $1.25bn | 4,949,848 |  | Added +1,197,478 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.04bn | 4,150,727 |  | Added +73,583 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $622.3m | 2,473,235 |  | Added +3,902 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $616.3m | 2,449,771 |  | Reduced −368,380 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $571.0m | 2,269,680 |  | Reduced −38,974 |
| [Ninety One UK Ltd](/funds/1418329.md) | 2026-06-30 | $522.0m | 2,075,004 |  | Reduced −2,229 |

## Recent filings

[All 1,798 filings](/companies/vrsn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:33 ET | [10-Q](/filings/0001014473-26-000039.md) | Quarterly report, period 2026-09-30 | 0001014473-26-000039 |
| 2026-10-22 | 16:06 ET | [8-K](/filings/0001014473-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014473-26-000038 |
| 2026-08-27 | 16:01 ET | [8-K](/filings/0001014473-26-000030.md) | 8.01 Other events | 0001014473-26-000030 |
| 2026-07-23 | 16:32 ET | [10-Q](/filings/0001014473-26-000028.md) | Quarterly report, period 2026-06-30 | 0001014473-26-000028 |
| 2026-07-23 | 16:08 ET | [8-K](/filings/0001014473-26-000026.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001014473-26-000026 |
| 2026-06-26 | 16:23 ET | [8-K](/filings/0001140361-26-026574.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-026574 |
| 2026-06-26 | 09:14 ET | [8-K](/filings/0001140361-26-026514.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-026514 |
| 2026-05-21 | 16:10 ET | [8-K](/filings/0001014473-26-000023.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001014473-26-000023 |
| 2026-04-23 | 16:32 ET | [10-Q](/filings/0001014473-26-000020.md) | Quarterly report, period 2026-03-31 | 0001014473-26-000020 |
| 2026-04-23 | 16:07 ET | [8-K](/filings/0001014473-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014473-26-000019 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001014473-26-000006.md), filed Feb 5, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1014473
- Tickers: VRSN
- Exchange: Nasdaq
- SIC code: 7371 Services-Computer Programming Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:31 ET. No prices; not investment advice.